R Squared Ltd bought a new position in CVS Health Co. (NYSE:CVS – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 4,140 shares of the pharmacy operator’s stock, valued at approximately $186,000.
Other large investors have also recently modified their holdings of the company. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at approximately $25,000. Ridgewood Investments LLC raised its holdings in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares in the last quarter. Livelsberger Financial Advisory bought a new stake in shares of CVS Health during the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new stake in shares of CVS Health in the 3rd quarter worth about $31,000. Finally, Reston Wealth Management LLC bought a new position in shares of CVS Health in the 3rd quarter worth about $32,000. Institutional investors own 80.66% of the company’s stock.
CVS Health Stock Down 0.6 %
CVS stock opened at $57.00 on Thursday. The business’s 50-day moving average is $51.27 and its two-hundred day moving average is $56.18. The company has a market cap of $71.73 billion, a price-to-earnings ratio of 14.47, a P/E/G ratio of 0.80 and a beta of 0.59. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.
CVS Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.67%. CVS Health’s payout ratio is currently 67.51%.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on CVS. TD Cowen upped their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Barclays reduced their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Truist Financial lowered their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.
Get Our Latest Stock Report on CVS Health
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- Options Trading – Understanding Strike Price
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.